Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: A pilot study

David G. Daniel, Terry E. Goldberg, Daniel R. Weinberger, Joel E. Kleinman, David Pickar, Lisa J. Lubick, Tracy S. Williams

Research output: Contribution to journalArticle

Abstract

Objective: The purpose of this study was to compare the side effect profiles of clozapine and risperidone. Method: The subjects were 20 outpatients with schizophrenia or schizoaffective disorder who were clinically stable on a regimen of clozapine at the time of screening. They underwent a randomized-order crossover comparison of 6 weeks of risperidone treatment and 6 weeks of clozapine treatment. Clinical and neurocognitive variables were assessed by raters blind to medication status, and severity of side effects was determined from patients' self-reports. Results: Side effect measures, but not clinical ratings, were significantly different after 6 weeks of treatment with the two drugs. Patients required more benztropine for motor effects and complained of more insomnia with risperidone and more sedation with clozapine. Body weight was higher at the end of clozapine treatment than at the end of risperidone treatment. Conclusions: In this exploratory study, the side effects profiles of clozapine and risperidone were consistent with the different pharmacodynamic profiles of the two drugs.

Original languageEnglish (US)
Pages (from-to)417-419
Number of pages3
JournalAmerican Journal of Psychiatry
Volume153
Issue number3
DOIs
StatePublished - Mar 1996

    Fingerprint

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this